Remdesivir for COVID-19: challenges of underpowered studies. Norrie JD. Lancet 2020;395:1525-1527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Norrie JD. Remdesivir for COVID-19: challenges of underpowered studies. Lancet 2020;395:1525-1527.
PMID: 32423580